Literature DB >> 12122206

Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.

Stephen B Beres1, Gail L Sylva, Kent D Barbian, Benfang Lei, Jessica S Hoff, Nicole D Mammarella, Meng-Yao Liu, James C Smoot, Stephen F Porcella, Larye D Parkins, David S Campbell, Todd M Smith, John K McCormick, Donald Y M Leung, Patrick M Schlievert, James M Musser.   

Abstract

Genome sequences are available for many bacterial strains, but there has been little progress in using these data to understand the molecular basis of pathogen emergence and differences in strain virulence. Serotype M3 strains of group A Streptococcus (GAS) are a common cause of severe invasive infections with unusually high rates of morbidity and mortality. To gain insight into the molecular basis of this high-virulence phenotype, we sequenced the genome of strain MGAS315, an organism isolated from a patient with streptococcal toxic shock syndrome. The genome is composed of 1,900,521 bp, and it shares approximately 1.7 Mb of related genetic material with genomes of serotype M1 and M18 strains. Phage-like elements account for the great majority of variation in gene content relative to the sequenced M1 and M18 strains. Recombination produces chimeric phages and strains with previously uncharacterized arrays of virulence factor genes. Strain MGAS315 has phage genes that encode proteins likely to contribute to pathogenesis, such as streptococcal pyrogenic exotoxin A (SpeA) and SpeK, streptococcal superantigen (SSA), and a previously uncharacterized phospholipase A(2) (designated Sla). Infected humans had anti-SpeK, -SSA, and -Sla antibodies, indicating that these GAS proteins are made in vivo. SpeK and SSA were pyrogenic and toxic for rabbits. Serotype M3 strains with the phage-encoded speK and sla genes increased dramatically in frequency late in the 20th century, commensurate with the rise in invasive disease caused by M3 organisms. Taken together, the results show that phage-mediated recombination has played a critical role in the emergence of a new, unusually virulent clone of serotype M3 GAS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122206      PMCID: PMC126627          DOI: 10.1073/pnas.152298499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.

Authors:  N P Hoe; K Nakashima; S Lukomski; D Grigsby; M Liu; P Kordari; S J Dou; X Pan; J Vuopio-Varkila; S Salmelinna; A McGeer; D E Low; B Schwartz; A Schuchat; S Naidich; D De Lorenzo; Y X Fu; J M Musser
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

2.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

Authors:  J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

3.  Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995.

Authors:  B Beall; R Facklam; T Hoenes; B Schwartz
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

4.  Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity.

Authors:  W L Hynes; L Hancock; J J Ferretti
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

5.  Studies on the subunit structure of textilotoxin, a potent presynaptic neurotoxin from the venom of the Australian common brown snake (Pseudonaja textilis). 3. The complete amino-acid sequences of all the subunits.

Authors:  J A Pearson; M I Tyler; K V Retson; M E Howden
Journal:  Biochim Biophys Acta       Date:  1993-02-13

6.  A theory of modular evolution for bacteriophages.

Authors:  D Botstein
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

7.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

8.  IS861, a group B streptococcal insertion sequence related to IS150 and IS3 of Escherichia coli.

Authors:  C E Rubens; L M Heggen; J M Kuypers
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

9.  Improved pattern for genome-based screening identifies novel cell wall-attached proteins in gram-positive bacteria.

Authors:  R Janulczyk; M Rasmussen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

View more
  218 in total

1.  Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution.

Authors:  Ichiro Nakagawa; Ken Kurokawa; Atsushi Yamashita; Masanobu Nakata; Yusuke Tomiyasu; Nobuo Okahashi; Shigetada Kawabata; Kiyoshi Yamazaki; Tadayoshi Shiba; Teruo Yasunaga; Hideo Hayashi; Masahira Hattori; Shigeyuki Hamada
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

2.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus.

Authors:  Stephen B Beres; Ellen W Richter; Michal J Nagiec; Paul Sumby; Stephen F Porcella; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

3.  Genetics of streptococci, lactococci, and enterococci: review of the sixth international conference.

Authors:  Janet Yother; Patrick Trieu-Cuot; Todd R Klaenhammer; Willem M De Vos
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

Review 4.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

5.  Genomic sequence of C1, the first streptococcal phage.

Authors:  Daniel Nelson; Raymond Schuch; Shiwei Zhu; Donna M Tscherne; Vincent A Fischetti
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

6.  Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes.

Authors:  Michael Binks; David McMillan; Kadaba S Sriprakash
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  In vivo lysogenic conversion of Tox(-) Streptococcus pyogenes to Tox(+) with Lysogenic Streptococci or free phage.

Authors:  Thomas B Broudy; Vincent A Fischetti
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Expression of the secondary sigma factor sigmaX in Streptococcus pyogenes is restricted at two levels.

Authors:  Jason A Opdyke; June R Scott; Charles P Moran
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

Review 9.  Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Authors:  Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

10.  Role of the C-terminal lysine residues of streptococcal surface enolase in Glu- and Lys-plasminogen-binding activities of group A streptococci.

Authors:  Anne Derbise; Youngmia P Song; Sonia Parikh; Vincent A Fischetti; Vijay Pancholi
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.